UNSPSC 51451901: Bromoxanide

This classification denotes an antihelminthic agent with the molecular formula C19H18BrF3N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9MM438AA0G, chemically known as 4-bromo-3-tert-butyl-alpha,alpha,alpha-trifluoro-5-nitro-2,6-cresoto-o-toluidide but generally known as bromoxanide, which bears US NIH Compound Identifier 166570. European Medicines Agency schedules Bromoxanide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05922MIG.

UNSPSC 51451901 Bromoxanide is a Commodity code that nominally identifies a single chemical compound, yet recent state and local solicitations tagged under it show little alignment with that specific product. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets — neither of which is bromoxanide. Separately, Seminole County, Florida posted an IFB (closing July 26, 2023, now expired) for procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, again unrelated to the code's nominal substance. The issuing bodies here represent a state health department and a county government, both sourcing pharmaceutical and medical-supply products for public health and community programs. Neither opportunity reflects actual bromoxanide procurement, and the code shows little relevant recent activity aligned with its stated commodity scope.

The geographic pattern in the limited available records spans Illinois and Florida, with no additional states represented in the recent opportunities. The Illinois contract, a completed award rather than an open solicitation, carried a total value of $2,999,999.11 over twelve months plus two optional renewal years and was conducted through an Invitation for Bid process. The Seminole County opportunity, also now closed, specified quarterly deliveries and included delivery-cost responsibility on vendors, with a two-year initial term and one-year renewal option. Neither solicitation directly targets bromoxanide as a procured item, suggesting this code may be misapplied to these opportunities or that state and local demand for bromoxanide specifically remains absent from current public contracting records.